Analysts Downgrade Merck and Pfizer on Patent Cliff, Exclusivity Concerns - IPWatchdog.com

Analysts Downgrade Merck and Pfizer on Patent Cliff, Exclusivity Concerns  IPWatchdog.com

Last month, business news outlets were reporting that stock prices for pharmaceutical firms Pfizer and Merck took a tumble after financial analysts downgraded ...